Clinical Trial Update: Investigation to Identify Predictors of Response to a Treatment With Montelukast [Phase 4]

View source ↗

Summary

Phase 4 investigation aimed at identifying predictors of response to montelukast in asthma. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Singulair) (montelukast)

Snippet

Sponsor: Marien Hospital Wesel | Conditions: Asthma | Phase 4 | Status: COMPLETED